To the attention of Marketing Authorisation Holders (MAHs) concerned
The National Agency for Medicines and Medical Devices (NAMMD) hereby informs on the document conveyed by the European Commission at the end of February 2019 to all human and veterinary medicines agencies of the 27 EU Member States on regulations for quality control of medicinal product batches in the context of Great Britain’s (UK) withdrawal from the Union.
download document …